Sage Journals: Discover world-class research

Open access

Research article

First published 2019-1

Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results

Robert T Naismith, Barry Hendin, Sibyl Wray [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Case report

First published 2018-2

Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection

Giancarlo Coghe, Laura Atzori, Jessica Frau [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2018-2

Commentary on “Localized pigmentation disorder after subcutaneous pegylated interferon beta 1a injection” by Coghe et al.

Bernadette Porter

Multiple Sclerosis Journal

Retricted access

Review article

First published 2010-10

PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis

Darren P. Baker, Robert Blake Pepinsky, Margot Brickelmaier [...]

Journal of Interferon & Cytokine Research

Open access

Research article

First published 2024-4

Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program

Marco Salvetti, Sibyl Wray, Gereon Nelles [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2017-01

Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma,Breast,Renal,and Colon Xenograft Models

Antonio Boccia, Cyrus Virata, Daniel Lindner [...]

Journal of Interferon & Cytokine Research

Open access

Research article

First published 2021

Bioequivalence of intramuscular and subcutaneous peginterferon beta-1a: results of a phase I,open-label crossover study in healthy volunteers

Yuan Zhao, Kun Chen, Nancy Ramia [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2024

Lower leukocytes pretreatment as a possible risk factor for therapy-induced leukopenia in interferon-beta-treated patients with multiple sclerosis

Maria Protopapa, Samantha Schmaul, Muriel Schraad [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2015-7

Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE

Bernd C Kieseier, Douglas L Arnold, Laura J Balcer [...]

Multiple Sclerosis Journal

Free access

Research article

First published 2017-1

Peginterferon beta-1a reduces disability worsening in relapsing–remitting multiple sclerosis: 2-year results from ADVANCE

Scott D. Newsome, Bernd C. Kieseier, Shifang Liu [...]

Therapeutic Advances in Neurological Disorders

Search results